Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00441493 · ClinicalTrials.gov registry record · NA
Fluvastatin Versus Hepatitis C Virus
A NA study, sponsored by Bader, Ted, M.D..
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT00441493: Completed NA study, sponsored by Bader, Ted, M.D..
NCT00441493 is a NA study that has completed, run by Bader, Ted, M.D.. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00441493, a NA study, has completed, sponsored by Bader, Ted, M.D..
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.
Interventions
- DRUG fluvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT00441493 record still lists
NCT00441493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which fluvastatin is the first listed.
NCT00441493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00441493 about?
NCT00441493 is a clinical study titled "Fluvastatin Versus Hepatitis C Virus". This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.
What is the current status of trial NCT00441493?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2006-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00441493?
The interventions under investigation include: fluvastatin (DRUG).
Who is sponsoring clinical trial NCT00441493?
This trial is sponsored by Bader, Ted, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00441493's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia